- Home
- SEAT vs RCKT Comparison
SEAT vs RCKT Comparison
Compare SEAT & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEAT
- RCKT
- Stock Information
- Founded
- SEAT 2001
- RCKT 1999
- Country
- SEAT United States
- RCKT United States
- Employees
- SEAT N/A
- RCKT N/A
- Industry
- SEAT Industrial Machinery/Components
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- SEAT Industrials
- RCKT Health Care
- Exchange
- SEAT Nasdaq
- RCKT Nasdaq
- Market Cap
- SEAT 366.2M
- RCKT 328.6M
- IPO Year
- SEAT N/A
- RCKT N/A
- Fundamental
- Price
- SEAT $16.92
- RCKT $3.59
- Analyst Decision
- SEAT Buy
- RCKT Buy
- Analyst Count
- SEAT 11
- RCKT 13
- Target Price
- SEAT $68.00
- RCKT $12.96
- AVG Volume (30 Days)
- SEAT 282.5K
- RCKT 5.8M
- Earning Date
- SEAT 08-05-2025
- RCKT 08-07-2025
- Dividend Yield
- SEAT N/A
- RCKT N/A
- EPS Growth
- SEAT N/A
- RCKT N/A
- EPS
- SEAT N/A
- RCKT N/A
- Revenue
- SEAT $694,007,000.00
- RCKT N/A
- Revenue This Year
- SEAT N/A
- RCKT N/A
- Revenue Next Year
- SEAT N/A
- RCKT $108.43
- P/E Ratio
- SEAT N/A
- RCKT N/A
- Revenue Growth
- SEAT N/A
- RCKT N/A
- 52 Week Low
- SEAT $15.13
- RCKT $2.19
- 52 Week High
- SEAT $100.00
- RCKT $22.01
- Technical
- Relative Strength Index (RSI)
- SEAT 34.43
- RCKT 57.73
- Support Level
- SEAT $16.61
- RCKT $3.31
- Resistance Level
- SEAT $17.40
- RCKT $3.98
- Average True Range (ATR)
- SEAT 0.98
- RCKT 0.25
- MACD
- SEAT 0.53
- RCKT 0.04
- Stochastic Oscillator
- SEAT 64.70
- RCKT 55.51
About SEAT Vivid Seats Inc.
Vivid Seats Inc is an online ticket marketplace for connecting fans to live events and artists. It is the official ticketing partner of brands in the entertainment industry providing tickets for sports, concerts, theatres, and comedy events in the United States, Canada and Japan. It operates in two segments namely marketplace and resale. Marketplace segment, act as an intermediary between ticket buyers, sellers, and partners through which company earn revenue from processing ticket sales for live events and facilitating the booking of hotel rooms and packages on websites and mobile applications. Resale segment provides internal research and development support for Skybox and supplements ongoing efforts to deliver software and tools. Majority of revenue is from Marketplace segment.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.